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The active efﬂux of antibiotics by multidrug-resistance (MDR) transporters is a
major pathway of drug resistance and complicates the clinical treatment of
bacterial infections. MdfA is a member of the major facilitator superfamily
(MFS) from Escherichia coli and provides resistance to a wide variety of
dissimilar toxic compounds, including neutral, cationic and zwitterionic
substances. The 12-transmembrane-helix MdfA was expressed as a GFP-
octahistidine fusion protein with a TEV protease cleavage site. Following tag
removal, MdfAwas puriﬁed using two chromatographic steps, complexed with a
Fab fragment and further puriﬁed using size-exclusion chromatography. MdfA
and MdfA–Fab complexes were subjected to both vapour-diffusion and lipidic
cubic phase (LCP) crystallization techniques. Vapour-diffusion-grown crystals
were of type II, with poor diffraction behaviour and weak crystal contacts. LCP
lipid screening resulted in type I crystals that diffracted to 3.4 A˚ resolution and
belonged to the hexagonal space group P6122.
1. Introduction
Active efﬂux by multidrug-resistance (MDR) transporters is a
major cause of bacterial resistance to many classes of anti-
biotics (Nikaido, 2009). MDR transporters can be classiﬁed
into primary transporters [such as ATP-binding cassette
(ABC) transporters] that utilize ATP hydrolysis as an energy
source, and secondary transporters, which utilize the energy
stored in the transmembrane electrochemical gradient. On the
basis of similarities in their sequences, the secondary trans-
porters are further categorized into at least four large super-
families, including the major facilitator superfamily (MFS), the
resistance–nodulation–division (RND) family, the multidrug
and toxic compounds extrusion (MATE) family and the small
multidrug-resistance (SMR) family (Putman et al., 2000).
Proteins belonging to the MFS play a major role in prokar-
yotic MDR, yet the mechanism of drug transport is not
entirely clear. The current accepted paradigm is that MFS
transporters utilize a ‘rocker-switch alternating access’
mechanism, whereby the N-terminal and C-terminal six-helix
bundles rotate with respect to each other about an axis within
the plane of the membrane that passes through the central
substrate-binding site. This mechanism requires at least
three states: inward open, outward open and a (potentially
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transient) occluded form that may be further divided into
inward and outward occluded states (Yan, 2013; Quistgaard et
al., 2016).
Sequence analysis of Escherichia coli MdfA suggested the
presence of 12 transmembrane (TM) helices, a hallmark of
the MFS (Edgar & Bibi, 1997; Sigal et al., 2006), which was
conﬁrmed by the recent crystal structures of ligand-bound
forms of MdfA in the inward-facing state (Heng et al., 2015;
Liu et al., 2016). MdfA is capable of coupling the efﬂux of a
number of lipophilic cationic, zwitterionic and neutral
substrates to the transmembrane proton (H+) or ion chemical
gradient, allowing it to translocate antibiotics such as
chloramphenicol, erythromycin, ethidium, tetraphenylphos-
phonium and rhodamine (Edgar & Bibi, 1997). A second
physiological function of MdfA is found in pH regulation
owing to its activity as an H+/Na+,K+ antiporter: knockout of
MdfA results in bacterial growth restriction under strongly
alkaline conditions (Lewinson et al., 2004).
Although MdfA can transport many structurally unrelated
compounds, it has been suggested that similar conformations
of the transporter are induced by the different permeant
substrates (Fluman et al., 2009), implying a common transport
mechanism within the framework of the rocker-switch model.
Two negatively charged residues located in TM helix 1 (Glu26
and Asp34) have been identiﬁed as playing critical roles in
substrate and proton transport (Edgar & Bibi, 1999; Fluman
et al., 2012). The postulated transport mechanism involves
competition between proton and substrate binding at these
two acidic residues in the binding cavity of MdfA. Speciﬁcally,
Asp34 is proposed to be involved in both proton and substrate
binding (supported by the chloramphenicol-bound structure;
Heng et al., 2015), while protonation of Glu26 is thought to
shift the conformation of the transporter from the outward
open state to the inward open state; interplay between these
two sites is thought to drive transport (Fluman et al., 2012).
For a complete understanding of substrate binding and the
transport mechanism, it is essential to identify and visualize
additional conformational states of MdfA. Key prerequisites
for structural analysis include homogenous and stable MdfA,
yet such preparations remain a challenge for membrane
proteins, which often suffer from poor expression levels and
loss of activity after extraction from their native membranes
by detergents. In addition, the resulting detergent micelle
surrounding the protein may hamper the protein crystal-
lization process and impact on the diffraction quality of
membrane-protein crystals. Co-crystallization of membrane
proteins with antibody fragments has been reported to be an
effective means of improving the diffraction quality of
membrane-protein crystals by limiting intrinsic ﬂexibility. In
addition, antibody binding increases the surface area exposed
from detergent micelles, which is often thought to be critical
for producing crystal contacts (Hino et al., 2013).
Prior to this study, we expressed and puriﬁed the MFS-type
MDR transporter MdfA from E. coli to generate and isolate
antibody Fab fragments against MdfA, with a view towards
using these as potential crystallization chaperones (Hino et al.,
2013). In this way, we were able to identify Fab fragments that
stabilize MdfA as measured using the N-[4-(7-diethylamino-
4-methyl-3-coumarinyl)phenyl]maleimide (CPM) thermo-
stability assay (Jaenecke et al., 2017). Here, we show that the
Fab fragment YN1074 is also able to suppress pH-dependent
stability changes in the transporter. The MdfA–YN1074
complex could be crystallized using both hanging-drop
vapour-diffusion and lipidic cubic phase (LCP) methods, and
we demonstrate that lipid screening has a signiﬁcant effect on
the quality of crystals grown using LCP. The best crystals grew
in LCP using the lipid 1-(8Z-hexadecenoyl)-rac-glycerol (8.8
MAG) and diffracted to a maximum resolution of 3.4 A˚.
2. Materials and methods
2.1. Macromolecule production
2.1.1. Materials. All general reagents and materials were
purchased from Sigma–Aldrich and Carl Roth, unless other-
wise speciﬁed. Ni2+–NTA resin was purchased from Qiagen.
The detergents n-dodecyl--d-maltopyranoside (DDM),
n-decyl--d-maltopyranoside (DM), n-nonyl--d-maltopyr-
anoside (NM) and lauryl maltose neopentyl glycol (LMNG)
were obtained from Anatrace (Maumee, Ohio, USA).
Monoolein was obtained from Nu-Chek Prep (Elysian,
Minnesota, USA) and other MAGs were purchased from
Avanti Polar lipids (Alabaster, Alabama, USA). Polyethylene
glycols (PEGs) for crystallization were obtained from Mole-
cular Dimensions, whereas other materials for crystallization
were obtained from Jena Biosciences, Hampton Research and
Rigaku Reagents.
2.1.2. Cloning of MdfA. The mdfA gene (NCBI GenBank
accession No. AAC73929.1 for E. coli K-12 substrain
MG1655) was ampliﬁed from E. coli Top10 cells and cloned
upstream of the TEV cleavage-site sequence (TEVcs) of
pWaldo-GFPe (Drew et al., 2001) via the XhoI and KpnI
restriction sites, allowing expression of the MdfA-(TEVcs)-
GFP-His8 fusion protein. Two nucleotides were introduced
between the gene sequences of mdfA and the TEVcs by site-
directed mutagenesis in order to ensure the correct reading
frame, using the oligonucleotides 50-TCGCACGAAGGGG-
GTACCTATGGATCCGAAAACCTGTAC-30 and 50-GTA-
CAGGTTTTCGGATCCATAGGTACCCCCTTCGTGCGA-
30. E. coli C43 (DE3) cells were transformed with this plasmid
and used for overexpression of the MdfA-(TEVcs)-GFP
fusion protein.
2.1.3. MdfA expression and purification. A single colony
was inoculated into LB medium containing kanamycin
(75 mg ml1) at 37C overnight. The overnight culture was
diluted (1:100; an OD600 of approximately 0.05) in 2 YT
medium supplemented with kanamycin and the cells were
grown at 37C to an optical density (OD600) of 0.4. The
temperature was decreased to 28C and expression of the
protein was induced by the addition of 0.4 mM IPTG. Cells
were harvested 6 h after induction by centrifugation at 5000g
for 10 min at 4C.
The cell pellets were resuspended in 20 mM Tris pH 7.5,
150 mM NaCl, 5 mM EDTA buffer supplemented with
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10 mg ml1 DNAseI, 1 mM PMSF and then disrupted by high-
pressure homogenization (APV homogenizers). Cell debris
was removed by centrifugation at 10 000g for 15 min, and the
membrane fraction was collected by ultracentrifugation at
100 000g for 90 min. Isolated membranes were ﬂash-frozen in
liquid nitrogen and stored at 80C. The membrane fraction
was solubilized in 150 ml solubilization buffer (25 mM Tris,
200 mM NaCl pH 7.3) containing 1% DDM; the detergents
DM, NM and LMNG were also screened, but only DDM
yielded a monodisperse peak in SEC. Insoluble material was
removed by centrifugation at 100 000g for 1 h and the solu-
bilized fraction was incubated with 10 ml Ni2+ beads (batch
binding) equilibrated in buffer A (20 mM Tris, 150 mM NaCl,
0.02% DDM pH 7.5) for 2 h. MdfA-GFP was puriﬁed by
immobilized Ni2+-afﬁnity chromatography, with 0.02% DDM
added to all buffers. The resin was washed with ﬁve column
volumes (CV) of buffer A containing 20 mM imidazole,
followed by 12 CV of buffer A containing 50 mM imidazole.
MdfA-GFP was eluted with buffer A containing 250 mM
imidazole, and fractions were pooled and exchanged with
buffer A to reduce the concentration of imidazole (to
10 mM) before treatment with TEV protease.
MdfA-GFP in the presence of a half-molar ratio of hexa-
histidine (His6)-tagged TEV protease (Drew et al., 2008) was
dialyzed overnight against buffer A supplemented with 1 mM
-mercaptoethanol at 4C using a 3 kDa molecular-weight
cutoff membrane. After dialysis, the sample was passed
through 15 ml Ni2+–NTA resin equilibrated in dialysis buffer
to separate the resulting MdfA (ﬂowthrough) from the
C-terminally His8-tagged GFP and the His6-tagged TEV
protease. The fraction containing MdfAwas concentrated and
applied onto a Superdex 200 10/300 GL size-exclusion chro-
matography (SEC) column equilibrated with buffer B (10 mM
MES, 20 mM NaCl, 0.02% DDM pH 7.0).
2.1.4. Preparation of Fab fragments. Fab fragments were
generated as described previously (Jaenecke et al., 2017;
Supplementary Fig. S1) according to established protocols
(Day et al., 2007). Brieﬂy, a proteoliposome antigen was
prepared by reconstituting puriﬁed, functional MdfA at high
density into phospholipid vesicles that consisted of a 10:1
mixture of egg phosphatidylcholine (Avanti Polar Lipids) and
the adjuvant lipid A (Sigma) to facilitate the immune
response. BALB/c mice were immunized with the proteo-
liposome antigen using three injections at two-week intervals.
Antibody-producing hybridoma cell lines were generated
using a conventional fusion protocol (Ko¨hler & Milstein, 1975;
Pontecorvo, 1976). Hybridoma clones producing antibodies
against MdfA were selected by an enzyme-linked immuno-
sorbent assay on immobilized phospholipid vesicles containing
puriﬁed MdfA (liposome ELISA), allowing positive selection
of those antibodies recognizing the native conformation of
MdfA. Additional screening for reduced antibody binding to
SDS-denatured MdfA was used to select against linear
epitope-recognizing antibodies (negative selection). Whole
IgG molecules, collected from large-scale culture supernatant
of monoclonal hybridomas and puriﬁed using protein G afﬁ-
nity chromatography, were digested with papain (Nacalai) and
Fab fragments were isolated using a Superdex 200 gel-
ﬁltration column followed by protein A afﬁnity chromato-
graphy (Bio-Rad). This procedure resulted in the isolation of
four MdfA-speciﬁc monoclonal antibodies (YN1006, YN1010,
YN1074 and YN1082), the Fab fragments of each of which
form a stable complex with the transporter that can be isolated
using SEC (Jaenecke et al., 2017).
2.1.5. Preparation of MdfA–Fab fragment YN1074
complexes. Puriﬁed MdfA was incubated with Fab fragment
YN1074 in a molar ratio of 1:1.5 for 16 h in buffer B prior to
SEC. Peak fractions containing MdfA–YN1074 complexes
were concentrated to 5 mg ml1 and used for crystallization.
In a second set of experiments, the pH of buffer B during both
MdfA–Fab complex formation and subsequent SEC and CPM
thermostability assays was modiﬁed in the range between pH
5.5 and 7.0.
2.1.6. Thermostability assays of MdfA and the MdfA–Fab
complex. CPM thermostability analysis was performed as
described by Alexandrov et al. (2008) with minor modiﬁca-
tions. Brieﬂy, 12 ml MdfA or MdfA–Fab complex (2 mg ml1)
was mixed with 45.6 ml buffer B and 2.4 ml CPM dye (at
5 mg ml1). The reaction mixture was transferred to a clean
PCR tube and heated from 25 to 90C at a rate of 1C min1 in
a Rotor Gene Q cycler (Qiagen). The ﬂuorescence of the dye
(excitation and emission wavelengths of 365 and 460 nm,
respectively) was monitored during the heating process.
Calculation of the ﬁrst derivative of the melting curve
(performed with the Rotor Gene Q software v.2.1.0) indicates a
maximum at the apparent transition temperature/melting
temperature Tm of the protein.
2.2. Crystallization
MdfA and the MdfA–YN1074 complex were concentrated
to 5 and 2.5 mg ml1, respectively, using a 100 kDa molecular-
weight cutoff Amicon (Millipore) prior to crystallization
screening. Crystallization trials using the vapour-diffusion
method were performed in 96-well sitting-drop plates using
a Cartesian MicroSys NQ crystallization robot (Zinsser
Analytic) with commercially available screening matrices
(MemPlus and MemGold2 from Molecular Dimensions as
well as Wizard I, II, III and IV from Rigaku Reagents).
Droplets containing equal volumes of reservoir solution
(200 nl) and protein solution (200 nl) were incubated against
70 ml of each reservoir solution at 16C.
Initial LCP crystallization setups were made by mixing
MdfA or the MdfA–YN1074 complex at 2.5, 5 or 10 mg ml1
with monoolein acyl-glycerol (9.9 MAG) in a 2:3 ratio using
the two-syringe coupling method (Caffrey & Cherezov, 2009).
Protein-containing LCP (100 nl) was dispensed over each well
of the Laminex glass plate (Molecular Dimensions) using a
LISSYII robot (Zinsser Analytic) and overlaid with 1 ml
precipitant solution from commercially available screening
matrices (MemGold, MemGold2, MemStart+MemSys and
MemMeso from Molecular Dimensions, JBScreen Membrane
and JBScreen Pentaerythritol from Jena Bioscience, Crystal
Screen HT, MemFac HT and Index HT from Hampton
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Research and Wizard 1 & 2 from Rigaku Reagents) for initial
screening. Subsequently, the MAG lipids were varied for the
MdfA–YN1074 complex using lipid mixing ratios of 1:1 {7.7
MAG [1-(7Z-tetradecenoyl)-rac-glycerol] and 7.8 MAG
[1-(7Z-pentadecenoyl)-rac-glycerol]} and 2:3 {7.9 MAG
[1-(7Z-hexadecenoyl)-rac-glycerol] and 8.8 MAG [1-(8Z-
hexadecenoyl)-rac-glycerol]}. All crystallization trials were
performed at 20C.
2.3. Data collection and processing
Prior to data collection, single crystals of MdfA and the
MdfA–YN1074 complex were harvested and ﬂash-cooled
directly in liquid nitrogen without additional cryoprotection.
All data were collected on beamline PXI (X06SA) at the Swiss
Light Source (SLS). For the MdfA and MdfA–YN1074
complex crystals grown using vapour diffusion, diffraction
data sets were collected at 100 K using a PILATUS 6M
detector, whereas diffraction data for the MdfA–YN1074
complex obtained from LCP were collected using an EIGER
16M detector. Diffraction data were processed and integrated
using XDS (Kabsch, 2010). Molecular replacement was
performed with Phaser (McCoy et al., 2007) to analyse crystal
packing using the coordinates of MdfA (PDB entry 4zp0;
Heng et al., 2015) and, where appropriate, a Fab fragment
(PDB entry 1ibg; Jeffrey et al., 1995) as search models (details
of the structure solution and analysis will be presented else-
where). Buried surface areas were calculated using the PISA
server (Krissinel & Henrick, 2007) and crystallographic ﬁgures
were prepared using PyMOL (Schro¨dinger).
3. Results and discussion
3.1. Cloning, expression and purification of MdfA
The PCR fragment coding for MdfA was successfully
inserted into the XhoI and KpnI sites of pWaldo-GFPe, which
was then transformed into E. coli C43 (DE3) cells (Table 1).
The expression level of MdfA-GFP was monitored by GFP
ﬂuorescence emission at 512 nm (excitation wavelength of
488 nm) using an ImageQuant LAS 4000 (GE Healthcare).
Following isolation of MdfA-GFP by single-step immobilized
metal-afﬁnity chromatography (IMAC), untagged MdfA was
obtained via TEV cleavage and a subsequent second IMAC
step, resulting in >90% purity (Fig. 1). Approximately 0.3–
0.4 mg of puriﬁed MdfAwas routinely obtained from 1 l of 2
YT medium.
3.2. Effect of Fab fragments on MdfA stability
At pH 7.0, the melting curve of MdfA shows an apparent
transition temperature Tm of 58C in the CPM assay, which
is increased by 4C in the complexes with Fabs YN1006,
YN1010 and YN1082 and by 12C in the presence of Fab
YN1074 (Jaenecke et al., 2017). The thermostability of puriﬁed
MdfA and the isolated MdfA–Fab YN1074 complex were
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Table 1
MdfA production information.
Source organism E. coli




Expression host E. coli C43 (DE3)
Complete amino-acid sequence















Puriﬁcation of the MdfA–YN1074 complex and pH-dependent thermo-
stability analyses of MdfA and the MdfA–YN1074 complex. (a) Size-
exclusion chromatograms of MdfA (green) and MdfA–YN1074 (purple)
on a Superdex 200 10/300 GL size-exclusion column. Inset: SDS–PAGE
analysis of the main SEC peaks. (b) Thermostability of MdfA/the MdfA–
YN1074 complex as a function of pH was assessed using the CPM thermal
denaturation assay. Apparent Tm values for MdfA and the MdfA–
YN1074 complex were evaluated from the ﬁrst derivative of the melting
curve.
electronic reprint
further analysed as a function of pH (Fig. 1b). Interestingly,
the antiporter exhibits an increased thermostability at lower
pH values (Tm of 66C at pH 5.5). In contrast, the complex
of MdfAwith the YN1074 Fab possesses a near-constant Tm of
71C at all tested pH values, demonstrating a stabilization of
MdfA by the Fab of 5–12C. The lack of variation of the Tm of
the complex with pH suggests that YN1074 stabilizes the low-
pH form of the antiporter and that MdfA–YN1074 may be
suitable for crystallization screening in a wide range of pH
conditions.
3.3. Crystallization of MdfA
In the initial crystallization trials, we used commercially
available screening kits with the sitting-drop vapour-diffusion
method (Supplementary Fig. S1). Microcrystals of MdfAwere
observed after 1–2 weeks from a number of conditions
containing PEG 400 as the precipitant (e.g. 0.1MMES pH 6.0,
0.2M Li2SO4, 25–30% PEG 400). These conditions were
optimized to improve the crystal morphology using the
hanging-drop vapour-diffusion method. The largest crystals
were obtained in 100 mM Tris pH 7.5, 100 mM NaCl, 100 mM
Li2SO4, 28–30% PEG 400 (MdfA-VD; Fig. 2a, Table 2), which
diffracted to resolutions lower than 7 A˚ (Supplementary Fig.
S2a). Processing of the diffraction data demonstrated that the
MdfA-VD crystal belonged to the hexagonal space group
P6122 or P6522, with unit-cell parameters a = b = 94.5,
c = 663.1 A˚ (Table 3).
In parallel, crystallization conditions for MdfA in complex
with the four Fabs were screened using vapour diffusion, and
(with the exception of Fab YN1010) crystals were obtained
(Supplementary Fig. S1). Nevertheless, the crystals of
MdfA–YN1006 and MdfA–YN1082 diffracted poorly, with a
maximum resolution of 30 A˚. Only those of the MdfA–
YN1074 complex, obtained in 100 mM HEPES pH 7, 100 mM
CdCl2, 100 mM LiCl, 24–28% PEG 400 within 3–5 d
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Figure 2
Crystals of MdfA andMdfA–YN1074. Crystals of (a) MdfA and (b) the MdfA–YN1074 complex grown by the hanging-drop vapour-diffusion method, as
well as of the MdfA–YN1074 complex grown using the LCP method with various host lipids: (c) 9.9 MAG, (d) 7.7 MAG, (e) 7.8 MAG, ( f ) 7.9 MAG and
(g) 8.8 MAG.
Table 2
Crystallization of MdfA and MdfA–YN1074.
Protein MdfA MdfA–YN1074 MdfA–YN1074
Method Hanging-drop vapour diffusion Hanging-drop vapour diffusion Lipidic cubic phase
Temperature (K) 289 289 293
Protein concentration (mg ml1) 5 2.5 2.5
Buffer composition of protein solution 10 mM MES, 20 mM NaCl,
0.02% DDM pH 7.0
10 mM MES, 20 mM NaCl,
0.02% DDM pH 7.0
10 mM MES, 20 mM NaCl,
0.02% DDM pH 7.0
Composition of reservoir solution 100 mM Tris pH 7.5, 100 mM NaCl,
100 mM Li2SO4, 28–30% PEG 400
100 mM HEPES pH 7, 100 mM CdCl2,
100 mM LiCl, 24–28% PEG 400
100 mM ADA pH 6.5, 100 mM NaCl,
100 mM Li2SO4, 32–36% PEG 300
Volume and ratio of drop 2 ml (1:1) 2 ml (1:1) 100 nl
Volume of reservoir 1 ml 1 ml 1 ml
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(MdfA–YN1074-VD; Fig. 2b, Table 2), diffracted to a maximal
resolution between 6 and 7 A˚ (Supplementary Fig. S2b). The
MdfA–YN1074-VD crystal belonged to the orthorhombic
space group P212121, with unit-cell parameters a = 76.6, b =
141.6, c = 296.6 A˚ (Table 3).
The limitations in obtaining diffraction-quality crystals via
the vapour-diffusion method prompted us to explore the
lipidic cubic phase (LCP) technique. The LCP medium is
ubiquitously used as an alternative to detergent micelles
during the crystallization of membrane proteins (Caffrey,
2015). Needle-shaped crystals of the MdfA–YN1074 complex
appeared in LCP using 9.9 MAG (the most frequently used
host lipid in initial LCP trials; Caffrey, 2015) in 100 mM
Tris pH 7.0, 100 mM NaCl, 100 mM Li2SO4, 40–44% PEG 300
(Fig. 2c). These crystals, which belonged to the hexagonal
space group P6122 or P6522, with unit-cell parameters
a = b = 73.3, c = 950.1 A˚, showed weak diffraction to 8 A˚
resolution.
We then screened the alkyl-chain length of the host lipid
between 14-C and 18-C, which is thought to improve the
partitioning of the membrane protein into the lipid and to
inﬂuence the curvature of the bicontinuous lipidic bilayer to
optimize the size of the aqueous channels to accommodate the
bound Fab (Li et al., 2013). Selection of lipids was informed
empirically by reported membrane-protein structures grown
by the LCP method (Caffrey, 2015). Crystallization in 7.7, 7.8
and 7.9 MAG generated small hexagonal crystals (<50 mm) in
100 mM ADA pH 6.5, 100 mM NaCl, 100 mM Li2SO4, 24–
26% PEG 300 (7.7 MAG), 100 mMADA pH 6, 100 mMNaCl,
100 mM Li2SO4, 28–30% PEG 300 (7.8 MAG) or 100 mM
ADA pH 6.5, 100 mM NaCl, 100 mM Li2SO4, 32–36% PEG
300 (7.9 MAG) (Figs. 2d, 2e and 2f), yet the diffraction quality
remained limited.
Crystals grown in 8.8 MAG as a host lipid appeared within
one week in 100 mM ADA pH 6.5, 100 mM NaCl, 100 mM
Li2SO4, 32–36% PEG 300 and matured to full size within
between ﬁve and seven weeks, when they were harvested
(MdfA–YN1074-LCP; Fig. 2g, Table 2). The morphology of
these larger crystals was hexagonal, and their maximal size
was 80–100 mm. These crystals diffracted to a resolution of
slightly over 3.0 A˚ (Supplementary Fig. S2c). Owing to the
presence of a very long c axis, the crystals were mounted
perpendicular to the beam with a slight tilt to best resolve the
closely spaced diffraction spots. Anisotropy of the diffraction
data restricted the resolution of the data set to 3.4 A˚. The
MdfA–YN1074-LCP crystal belonged to the hexagonal space
group P6122 or P6522, with unit-cell parameters a = b = 73.2,
c = 927.9 A˚ (i.e. related to those obtained using 9.9 MAG but
with a 22 A˚ shorter c axis). Data-collection and processing
statistics are summarized in Table 3.
The crystal packing in three of the crystal forms was
analysed following molecular replacement (details of the
structure solution and analysis will be presented elsewhere).
Two MdfA molecules (solvent content of 74.5%) could be
located in the asymmetric unit of the MdfA-VD crystal
(Fig. 3a), two transporter–Fab complexes (solvent content of
71.6%) in that of MdfA–YN1074-VD (Figs. 3b and 3c) and
one complex (solvent content 68.1%) in the asymmetric unit
of MdfA–YN1074-LCP (Figs. 3d and 3e). In each crystal form,
individual MdfA molecules associate laterally via their trans-
membrane regions (although the residues that contact each
other differ), with adjacent monomers facing in opposite
directions (Fig. 3).
In the MdfA-VD crystal (Fig. 3a), hydrophobic TM-helix
residues are responsible for most intermolecular contacts, with
buried surface areas of 800 A˚2 between monomers within the
asymmetric unit and 614 A˚2 between crystallographically
related monomers. This results in the formation of super-
helical ‘chains’ of MdfA molecules with their helix axes
parallel to the crystallographic sixfold screw axis. The contacts
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Table 3
Data collection and processing.







(lipidic cubic phase method)
Diffraction source PXI (X06SA), SLS PXI (X06SA), SLS PXI (X06SA), SLS
Wavelength (A˚) 1.000 1.000 1.000
Temperature (K) 100 100 100
Detector PILATUS 6M PILATUS 6M EIGER 16M
Space group P6522 P212121 P6122
a, b, c (A˚) 94.5, 94.5, 663.1 76.6, 141.6, 296.6 73.2, 73.2, 927.9
, ,  () 90, 90, 120 90, 90, 90 90, 90, 120
Resolution range (A˚) 50–7.82 (8.28–7.82) 50–7.06 (7.48–7.06) 49–3.40 (3.61–3.40)
Total No. of reﬂections 39028 32684 384466
No. of unique reﬂections 3376 9469 22224
CC1/2 (%) 100 (69.0) 99.9 (76.5) 100 (58.3)
Rmeas (%) 9.7 (122.2) 6.0 (61.4) 26.2 (172.4)
hI/(I)i 9.04 (1.65) 11.49 (2.01) 11.57 (1.59)†
Completeness (%) 99.1 (98.4) 98.3 (94.3) 99.9 (99.9)
Multiplicity 9.97 (9.77) 3.45 (3.44) 17.3 (16.03)
Mosaicity () 0.229 0.286 0.097
Solvent content (%) 74.5 71.6 68.1
No. of molecules/complexes per asymmetric unit 2 2 1
† The I/(I) falls below 2.0 at 3.4 A˚ resolution. The resolution cutoff was determined by the CC1/2 value (Karplus & Diederichs, 2012), which is 58.3% (our cutoff value is below 50%).
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between adjacent chains, involving residues from the
hydrophilic cytoplasmic and periplasmic surfaces of the
transporter, are weak, burying a surface area of only 97 A˚2.
The large spaces observed between the chains are presumably
occupied by detergent micellar structures.
As expected, the intermolecular contacts in the MdfA–
YN1074-VD crystal (Figs. 3b and 3c) are dominated by
multiple Fab–Fab interactions, which bury a total surface area
of 1179 A˚2. This is comparable to that of the MdfA–YN1074
interface (936 A˚2). Lateral hydrophobic contacts between
MdfA molecules are restricted to the interface within the
asymmetric unit, with a buried surface area of 707 A˚2, whereas
crystal contacts between the periplasmic faces of MdfA bury
307 A˚2. The complexes are arranged in rippled stacks within
the crystals, with inter-stack contacts provided by the Fabs
(Fig. 3c). As in the MdfA-VD crystals, the interlayer spaces
between MdfA molecules provide space for (presumably
disordered) detergent.
In contrast to the type II membrane-protein crystals formed
using vapour diffusion, the MdfA–YN1074-LCP crystal is of
type I, with the MdfA molecules forming an inﬁnite two-
dimensional array as in a membrane, albeit with alternate
facing monomers (Figs. 3d and 3e). Within this two-
dimensional layer, two sets of lateral hydrophobic contacts are
made, burying 1189 and 768 A˚2. Alternate layers are
connected by Fab–Fab interactions that bury a total surface
area of 900 A˚2. The favourable partitioning of intramembrane
and hydrophilic contacts observed in the packing of these
crystals is presumably responsible for their superior diffrac-
tion qualities.
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Figure 3
Crystal packing in MdfA crystals. Packing arrangements of (a) the transporter (MdfA-VD), (b, c) the MdfA–YN1074 complex within vapour-diffusion-
grown (MdfA–YN1074-VD) crystals and (d, e) the MdfA–YN1074 membrane-protein complex within lipidic cubic phase-grown crystals (MdfA–
YN1074-LCP). Selected symmetry-element symbols are shown for orientation. (a) The twoMdfA monomers (green, cyan) within the asymmetric unit of
MdfA-VD align to form inﬁnite superhelical chains (dotted line) that are stabilized by lateral hydrophobic contacts. Individual chains contact each other
via a small number of hydrophilic contacts. View parallel to the crystallographic a axis. (b) Crystal contacts in MdfA–YN1074-VD are dominated by
interactions between the Fabs (yellow, pink) from symmetry-related molecules. Within the lattice, the molecules are arranged in rippled layers (dotted
line), with major contacts between the layers provided by the Fabs. The view is parallel to the crystallographic a axis. (c) One layer from (b), viewed
parallel to the crystallographic b axis. (d) In the MdfA–YN1074-LCP crystals, MdfA (green; for clarity, twofold symmetry-related molecules are shown in
cyan, although these are crystallographically equivalent) is found in a two-dimensional membrane-like array. MdfA layers sandwich those of the Fab
YN1074 (yellow; pink), resulting in a favourable segregation of hydrophobic and hydrophilic crystal contacts. The view is parallel to the crystallographic
a axis. (e) The MdfA layer from (d), viewed parallel to the crystallographic c axis.
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Although the data presented here by no means present a
complete picture of the membrane-protein crystallization
process, some conclusions may be drawn. Thus, it seems that
the lipidic cubic phase facilitates optimal lateral contacts
between membrane-protein molecules, supported by the fact
that type I crystal formation appears to be typical for crystals
obtained in LCP (Caffrey, 2015). In contrast, the arrangements
in the vapour-diffusion crystals suggest that masking of the
hydrophobic membrane-facing surfaces by detergent mole-
cules prevents such two-dimensional arrangements. Coupled
with the need to accommodate bulky disordered detergent
micellar structures within the lattice, this results in weak
crystal contacts and therefore poor diffraction. As observed
previously (Hino et al., 2013), complexation with antibody
fragments can (in addition to stabilizing a particular confor-
mation in ﬂexible membrane proteins) increase the likelihood
of obtaining three-dimensional crystals. In our case, however,
it appears that Fab crystal contacts should be balanced by
favourable membrane-protein interactions within the lattice
for suitable diffraction properties, as observed in our LCP-
grown crystals. Finally, the nature of the host lipid exhibits a
pronounced inﬂuence both on the morphology and the
diffraction quality of the LCP crystals. The fact that we
observe a substantial change in the c axis for crystals grown
using 8.8 MAG and 9.9 MAG suggests that the different lipids
inﬂuence the two-dimensional packing of the membrane-
protein layer and/or the orientation of the MdfA molecules, in
turn inﬂuencing the positioning of the Fabs and allowing
optimization of the crystal packing and diffraction quality.
Structural analyses of MdfA will be presented elsewhere.
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Supporting Information   
 
 
Fig. S1. Flowchart for crystallization of MdfA. The diagram provides a summary of the strategy for 
generating and optimizing MdfA crystals used in this study. The contribution of Fab for crystallization trials of 
MdfA were analyzed by 96-well formatted sitting-drop vapor diffusion method. The commercial available 
screens MemGold2, MemPlus, Wizard I & II, and Wizard III & IV were tested for initital screening for vapor 
diffusion crystallization trials (336 crystallization conditions in total). MemGold, MemGold2, MemStart & 
MemSys, MemMeso, JBScreen Membrane, and JBScreen Pentaerythritol, Crystal screen HT, MemFac HT, 
Index HT and Wizard I & II, were tested for LCP crystallization method (960 crystallization conditions in total). 
#N.P represents the crystal diffracted more than 7-8 Å (likely 5-6Å) but not processible, because of weak and 
smear diffraction images.  
  
Fig. S2. Representative X-ray diffraction patterns. Diffraction images from crystals of (a) 
uncomplexed MdfA grown by the vapor diffusion method (MdfA-VD), (b) the MdfA-YN1074 
complex grown by vapor diffusion (MdfA-YN1074-VD) and (c) the MdfA-YN1074 complex 
using the LCP method with 8.8 MAG (MdfA-YN1074-LCP). 
 
